Regional Centers of Excellence for Biodefense and Emerging Infectious Diseases Research (RCE) [U54]
The summary for the Regional Centers of Excellence for Biodefense and Emerging Infectious Diseases Research (RCE) [U54] Federal Grant is detailed below.
It contains information such as the Catalog of Federal Domestic Assistance (CFDA) number, who is eligible for the grant, how much grant money will be awarded, important deadlines, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed in the Grant Announcement Contact section.
If these sections are incomplete, please visit the website of the government agency that is offering this grant.
Federal Grant Title:
REGIONAL CENTERS OF EXCELLENCE FOR BIODEFENSE AND EMERGING INFECTIOUS DISEASES RESEARCH (RCE) [U54]
Small businesses Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education Public and State controlled institutions of higher education Others (see text field entitled "Additional Information on Eligibility" for clarification) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education For profit organizations other than small businesses
Additional Information on Eligibility
Foreign institutions are not eligible to apply.
Purpose: The purpose of this Funding Opportunity Announcement (FOA) is to continue support for the Regional Centers of Excellence for Biodefense and Emerging Infectious Diseases Research (RCE) Program. The overall goal of the RCE Program is to establish and maintain strong infrastructure and multifaceted research and development activities to provide scientific information and translational research capacity that will facilitate the next generation of therapeutics, diagnostics and vaccines against the NIAID Category A-C Priority Pathogens (http://www3.niaid.nih.gov/topics/BiodefenseRelated/Biodefense/default.htm) and emerging infectious diseases (EID) agents (http://www3.niaid.nih.gov/research/topics/emerging/list.htm). Mechanism of Support: This FOA will use the NIH Specialized Centers Cooperative Agreement funding mechanism (U54). Funds Available and Anticipated Number of Awards: The NIAID expects to commit approximately $91 million in FY 2009 to support up to 10 awards in the range of $3 million to 12 million direct costs per year each. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications.